Corundum Trust Company’s Medtronic MDT Stock Holding History

Corundum Trust Company’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-279	Closed	-$26.6K	–	92
2025 Q3	$26.6K	Buy	+279	New	+$25.6K	0.06%	95

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Corundum Trust Company's MDT Position: Q4 2025 in Review

Corundum Trust Company sold out of Medtronic (MDT) in Q4 2025, closing a stake of 279 shares — an estimated $26.6K sold.

Corundum Trust Company first reported a position in MDT in Q3 2025 and held it in 1 quarter. The position peaked at $26.6K in Q3 2025. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

Corundum Trust Company reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
Corundum Trust Company sold 279 Medtronic shares in Q4 2025, an estimated $26.6K.
Corundum Trust Company first reported a position in Medtronic in Q3 2025 and held it in 1 quarter.
Corundum Trust Company's Medtronic position peaked at $26.6K in Q3 2025.
2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Corundum Trust Company's 13F filing for Q4 2025, filed 20 Jan 2026.